Use of Thermography for the Prevention and Diagnosis of Diabetic Foot

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-80
SponsorUniversity of Seville

About this trial

Diabetic foot is a serious complication of diabetes mellitus that can lead to ulcerations, infections and, in extreme cases, amputations. Early detection of changes in skin temperature can help prevent these complications. Infrared thermography is a noninvasive technique that allows the visualization and quantification of skin temperature and could be an effective tool for the early detection of alterations in diabetic foot.

Objective

To evaluate the effectiveness of infrared thermography in the early detection and diagnosis of diabetic foot, comparing the temperatures of the feet of healthy subjects and subjects with diabetic foot.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

Healthy subjects or those with type 2 diabetes mellitus for more than 5 years who wish to participate in the study voluntarily, who will undergo a thermography of both feet.

Trial design

Design model

Case-control

Time perspective

Prospective

Treatments tested in this trial

  • Termography

    Diagnostic test

    Thermographic images of both feet will be taken in multiple views (dorsal, plantar, lateral).

Treatment groups

100 Participants
are divided into 2 treatment groups
Group A: healthy patients1 intervention
Group B: diabetic foot patients1 intervention

Trial outcomes

Primary outcomes

1

Temperature maximun

Maximum foot temperatures

Time frame
One measurement will be taken at the start of the study and another measurement the following year.
2

Temperature minimum

Minimum foot temperatures

Time frame
One measurement will be taken at the start of the study and another measurement the following year.

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: